<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_apoptosis" title="HOXA9 Transcriptionally Promotes Apoptosis and Represses Autophagy by Targeting NF-κB in Cutaneous Squamous Cell Carcinoma" shortTitle="apoptosis" author="Shuo Han, Xue Li, Xiaoting Liang, Liang Zhou" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2073-4409/8/11/1360/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Cutaneous	JJ	Cutaneous
squamous	JJ	squamous
cell	NN	cell
carcinoma	NN	carcinoma
(	-LRB-	(
cSCC	NNP	cSCC
)	-RRB-	)
is	VBZ	be
the	DT	the
second	JJ	second
most	RBS	most
common	JJ	common
type	NN	type
of	IN	of
cancer	NN	cancer
with	IN	with
an	DT	a
annual	JJ	annual
incidence	NN	incidence
of	IN	of
over	RB	over
one	CD	one
million	CD	1000000
globally	RB	globally
.	.	.
</s>
<s type="decl">
Chronic	JJ	Chronic
ultraviolet	NN	ultraviolet
(	-LRB-	(
UV	NN	UV
)	-RRB-	)
exposure	NN	exposure
was	VBD	be
suggested	VBN	suggest
to	TO	to
be	VB	be
responsible	JJ	responsible
for	IN	for
DNA	NN	DNA
damage	NN	damage
of	IN	of
normal	JJ	normal
keratinocytes	NNS	keratinocyte
in	IN	in
the	DT	the
epidermis	NN	epidermis
,	,	,
which	WDT	which
leads	VBZ	lead
to	IN	to
the	DT	the
development	NN	development
of	IN	of
skin	NN	skin
cancers	NNS	cancer
including	VBG	include
cSCC	NNP	cSCC
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
detailed	JJ	detailed
underlying	JJ	underlie
molecular	JJ	molecular
mechanisms	NNS	mechanism
for	IN	for
this	DT	this
transition	NN	transition
still	RB	still
need	VBP	need
to	TO	to
be	VB	be
fully	RB	fully
elucidated	VBN	elucidate
.	.	.
</s>
</p>
<p>
<s type="decl">
Apoptosis	NNP	Apoptosis
is	VBZ	be
one	CD	one
type	NN	type
of	IN	of
programmed	VBN	programme
cell	NN	cell
death	NN	death
,	,	,
which	WDT	which
is	VBZ	be
initiated	VBN	initiate
by	IN	by
intrinsic	JJ	intrinsic
or	CC	or
extrinsic	JJ	extrinsic
signals	NNS	signal
and	CC	and
finely-tuned	RB	finely-tuned
by	IN	by
many	JJ	many
factors	NNS	factor
including	VBG	include
BCL-2	NNP	BCL-2
family	NN	family
proteins	NNS	protein
.	.	.
</s>
<s type="decl">
BCL-2	NNP	BCL-2
family	NN	family
members	NNS	member
,	,	,
including	VBG	include
both	CC	both
anti-apoptotic	JJ	anti-apoptotic
and	CC	and
pro-apoptotic	JJ	pro-apoptotic
BCL-2	NNP	BCL-2
family	NN	family
proteins	NNS	protein
,	,	,
govern	VBP	govern
mitochondrial	JJ	mitochondrial
outer	JJ	outer
membrane	NN	membrane
permeabilization	NN	permeabilization
(	-LRB-	(
MOMP	NNP	MOMP
)	-RRB-	)
to	TO	to
regulate	VB	regulate
apoptosis	NN	apoptosis
.	.	.
</s>
<s type="decl">
When	WRB	when
apoptotic	JJ	apoptotic
cell	NN	cell
death	NN	death
program	NN	program
starts	VBZ	start
,	,	,
MOMP	NNP	MOMP
releases	VBZ	release
cytochrome	NN	cytochrome
c	NN	c
to	IN	to
cytosol	NN	cytosol
and	CC	and
activates	VBZ	activate
caspase-family	NN	caspase-family
proteases	NNS	protease
for	IN	for
initiating	VBG	initiate
apoptotic	JJ	apoptotic
events	NNS	event
.	.	.
</s>
<s type="decl">
Tumors	NNS	tumor
develop	VBP	develop
effective	JJ	effective
mechanisms	NNS	mechanism
to	TO	to
resist	VB	resist
apoptosis	NN	apoptosis
and	CC	and
thus	RB	thus
become	VBP	become
one	CD	one
of	IN	of
the	DT	the
hallmark	JJ	hallmark
features	NNS	feature
of	IN	of
cancer	NN	cancer
.	.	.
</s>
<s type="decl">
The	DT	the
lead	NN	lead
member	NN	member
BCL-2	NNP	BCL-2
and	CC	and
its	PRP$	its
homologue	NN	homologue
BCL-XL	NNP	BCL-XL
(	-LRB-	(
BCL2L1	NNP	BCL2L1
)	-RRB-	)
are	VBP	be
featured	VBN	feature
by	IN	by
the	DT	the
presence	NN	presence
of	IN	of
four	CD	4
conserved	VBN	conserve
BH	NNP	BH
domains	NNS	domain
,	,	,
three	CD	3
of	IN	of
which	WDT	which
,	,	,
BH1	NNP	BH1
,	,	,
BH2	NNP	BH2
,	,	,
and	CC	and
BH3	NNP	BH3
domains	NNS	domain
,	,	,
are	VBP	be
responsible	JJ	responsible
for	IN	for
their	PRP$	their
antiapoptotic	JJ	antiapoptotic
role	NN	role
mainly	RB	mainly
by	IN	by
interactions	NNS	interaction
with	IN	with
other	JJ	other
proapoptotic	JJ	proapoptotic
members	NNS	member
of	IN	of
the	DT	the
BCL-2	NNP	BCL-2
family	NN	family
.	.	.
</s>
<s type="decl">
Inhibiting	VBG	inhibit
the	DT	the
activities	NNS	activity
of	IN	of
anti-apoptotic	JJ	anti-apoptotic
BCL-2	NN	BCL-2
members	NNS	member
by	IN	by
drugs	NNS	drug
or	CC	or
neutralizing	VBG	neutralize
by	IN	by
BH3	NNP	BH3
peptides	NNS	peptide
to	IN	to
prime	JJ	prime
cancer	NN	cancer
cells	NNS	cell
to	IN	to
death	NN	death
has	VBZ	have
been	VBN	be
regarded	VBN	regard
as	IN	as
effective	JJ	effective
therapeutic	JJ	therapeutic
modalities	NNS	modality
.	.	.
</s>
<s type="decl">
In	IN	in
another	DT	another
way	NN	way
,	,	,
transcriptionally	RB	transcriptionally
or	CC	or
post-transcriptionally	RB	post-transcriptionally
repressing	VBG	repress
the	DT	the
expression	NN	expression
levels	NNS	level
of	IN	of
anti-apoptotic	JJ	anti-apoptotic
BCL-2	NNP	BCL-2
members	NNS	member
in	IN	in
cancer	NN	cancer
is	VBZ	be
also	RB	also
promising	JJ	promising
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
mechanism	NN	mechanism
regulating	VBG	regulate
the	DT	the
expression	NN	expression
of	IN	of
BCL-2	NNP	BCL-2
family	NN	family
members	NNS	member
still	RB	still
remain	VBP	remain
unclear	JJ	unclear
.	.	.
</s>
</p>
<p>
<s type="decl">
Autophagy	NNP	Autophagy
is	VBZ	be
an	DT	a
evolutionarily-conserved	JJ	evolutionarily-conserved
catabolic	JJ	catabolic
process	NN	process
,	,	,
during	IN	during
which	WDT	which
“	``	''
useless	JJ	useless
”	''	''
proteins	NNS	protein
and	CC	and
damaged	VBN	damage
organelles	NNS	organelle
are	VBP	be
sequestrated	VBN	sequestrate
into	IN	into
autophagosomes	NNS	autophagosome
and	CC	and
fused	VBN	fuse
with	IN	with
lysosomes	NNS	lysosome
to	TO	to
form	VB	form
autolysosomes	NNS	autolysosome
for	IN	for
bulk	NN	bulk
degradation	NN	degradation
of	IN	of
embedded	VBN	embd
components	NNS	component
.	.	.
</s>
<s type="decl">
Except	IN	except
the	DT	the
dysregulated	JJ	dysregulated
autophagic	JJ	autophagic
process	NN	process
defined	VBN	define
as	IN	as
type	NN	type
II	CD	II
programmed	VBN	programme
cell	NN	cell
death	NN	death
,	,	,
autophagy	NN	autophagy
is	VBZ	be
generally	RB	generally
regarded	VBN	regard
as	IN	as
protective	JJ	protective
cellular	JJ	cellular
process	NN	process
.	.	.
</s>
<s type="decl">
The	DT	the
recycled	VBN	recycle
peptides	NNS	peptide
,	,	,
nucleotides	NNS	nucleotide
and	CC	and
lipids	NNS	lipid
together	RB	together
with	IN	with
the	DT	the
energy	NN	energy
are	VBP	be
critical	JJ	critical
to	IN	to
the	DT	the
maintenance	NN	maintenance
of	IN	of
cellular	JJ	cellular
homeostasis	NN	homeostasis
and	CC	and
support	VBP	support
tumor	NN	tumor
cells	NNS	cell
to	TO	to
survive	VB	survive
under	IN	under
stressful	JJ	stressful
environment	NN	environment
.	.	.
</s>
<s type="decl">
Autophagy-related	JJ	Autophagy-related
genes	NNS	gene
(	-LRB-	(
ATGs	NNS	ato
)	-RRB-	)
,	,	,
including	VBG	include
ULK1	NNP	ULK1
(	-LRB-	(
ATG1	NNP	ATG1
)	-RRB-	)
,	,	,
ATG3	NNP	ATG3
,	,	,
and	CC	and
ATG12	NNP	ATG12
etc.	FW	etc.
,	,	,
are	VBP	be
involved	VBN	involve
in	IN	in
the	DT	the
distinct	JJ	distinct
stages	NNS	stage
of	IN	of
autophagy	NN	autophagy
:	:	:
initiation	NN	initiation
,	,	,
autophagosome	NN	autophagosome
nucleation	NN	nucleation
,	,	,
autophagosome	NN	autophagosome
membrane	NN	membrane
expansion	NN	expansion
,	,	,
fusion	NN	fusion
with	IN	with
lysosome	NN	lysosome
and	CC	and
the	DT	the
intravesicular	JJ	intravesicular
components	NNS	component
degradation	NN	degradation
.	.	.
</s>
<s type="decl">
Signaling	VBG	signal
pathways	NNS	pathway
or	CC	or
critical	JJ	critical
factors	NNS	factor
are	VBP	be
involved	VBN	involve
in	IN	in
regulating	VBG	regulate
ATG	NNP	ATG
genes	NNS	gene
,	,	,
including	VBG	include
Class	NNP	Class
III	CD	III
PI3-kinase	NNP	PI3-kinase
complex	NN	complex
I	CD	I
,	,	,
mTORC	NNP	MTORC
I	NNP	I
complex	JJ	complex
,	,	,
mTORC	NNP	MTORC
II	NNP	II
complex	NN	complex
and	CC	and
Beclin1	NNP	Beclin1
et	FW	et
al.	FW	al.
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
transcriptional	JJ	transcriptional
regulation	NN	regulation
of	IN	of
the	DT	the
ATG	NNP	ATG
genes	NNS	gene
is	VBZ	be
not	RB	not
fully	RB	fully
explored	VBN	explore
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
our	PRP$	our
previous	JJ	previous
study	NN	study
,	,	,
Homeobox	NNP	Homeobox
A9	NNP	A9
(	-LRB-	(
HOXA9	NNP	HOXA9
)	-RRB-	)
was	VBD	be
significantly	RB	significantly
downregulated	VBN	downregulate
and	CC	and
identified	VBN	identify
as	IN	as
tumor	NN	tumor
suppressor	NN	suppressor
in	IN	in
cSCC	NN	cSCC
tumors	NNS	tumor
and	CC	and
cells	NNS	cell
.	.	.
</s>
<s type="decl">
HOXA9	NNP	HOXA9
functions	VBZ	function
in	IN	in
repressing	VBG	repress
the	DT	the
proliferation	NN	proliferation
,	,	,
migration	NN	migration
and	CC	and
invasiveness	NN	invasiveness
,	,	,
while	IN	while
promoting	VBG	promote
apoptosis	NN	apoptosis
of	IN	of
cSCC	NNP	cSCC
cells	NNS	cell
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
mechanisms	NNS	mechanism
about	IN	about
how	WRB	how
HOXA9	NNS	HOXA9
regulate	VBP	regulate
apoptosis	NN	apoptosis
has	VBZ	have
not	RB	not
been	VBN	be
explored	VBN	explore
and	CC	and
remain	VBP	remain
to	TO	to
be	VB	be
elucidated	VBN	elucidate
.	.	.
</s>
<s type="decl">
In	IN	in
this	DT	this
study	NN	study
,	,	,
we	PRP	we
found	VBD	find
RELA	NNP	RELA
(	-LRB-	(
p65	NN	p65
subunit	NN	subunit
of	IN	of
NF-κB	NNP	NF-κB
)	-RRB-	)
is	VBZ	be
transcriptionally	RB	transcriptionally
repressed	VBN	repress
by	IN	by
HOXA9	NNP	HOXA9
.	.	.
</s>
<s type="decl">
In	IN	in
cSCC	NNP	cSCC
,	,	,
RELA	NNP	RELA
transactivates	VBZ	transactivate
<hi rend="italic">
BCL-XL	NNP	BCL-XL
</hi>
to	TO	to
antagonize	VB	antagonize
apoptosis	NN	apoptosis
and	CC	and
ATG	NNP	ATG
genes	NNS	gene
(	-LRB-	(
<hi rend="italic">
ULK1	NNP	ULK1
</hi>
,	,	,
<hi rend="italic">
ATG3	NNP	ATG3
</hi>
,	,	,
and	CC	and
<hi rend="italic">
ATG12	NNP	ATG12
</hi>
)	-RRB-	)
to	TO	to
promote	VB	promote
autophagy	NN	autophagy
.	.	.
</s>
<s type="decl">
Our	PRP$	our
study	NN	study
highlights	VBZ	highlight
a	DT	a
HOXA9-NF-κB	NN	hoxa9-nf-κb
axis	NN	axis
regulates	VBZ	regulate
both	CC	both
the	DT	the
apoptosis	NN	apoptosis
and	CC	and
autophagy	NN	autophagy
to	TO	to
promote	VB	promote
tumor	NN	tumor
development	NN	development
in	IN	in
cSCC	NN	cSCC
,	,	,
which	WDT	which
may	MD	may
suggest	VB	suggest
novel	JJ	novel
intervention	NN	intervention
targets	NNS	target
for	IN	for
cSCC	NN	cSCC
therapy	NN	therapy
.	.	.
</s>
</p>
</text>